Potential anti-dementia agents in traditional Chinese medicine

Natural Product Communications

Volumn 4, Issue 6, 2009, Pages 877-886

  Li, Xue Juan ^a   Zhang, Hong Yu ^b  

^a SHANDONG UNIVERSITY OF TECHNOLOGY   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Dementia; Formula; Multi component therapeutics; Traditional Chinese medicine

Indexed keywords

ALPHA VINIFERIN; ARALOSIDE A; BERBERINE; CISTANOSIDE A; CISTANOSIDE C; CRYPTOTANSHINONE; DEHYDROEVODIAMINE; DIHYDROTANSHINONE; ERINACINE A; FANGQUINOLINE; GINKGOLIDE A; GLAZIOVINE; GLYCYRRHISOFLAVONE; HIGENAMINE; HONOKIOL; HUPERZINE A; LICOCOUMARONE; LYCORAMINE; MAGNOLOL; NOOTROPIC AGENT; OSTHOLE; PALMATINE; PROSTALIDIN; ROSMARINIC ACID; SANGUINARINE; SUBEROGORGIN; SYRINGIN; TETRAHYDROALSTONINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSOLIC ACID; CENTRAL NERVOUS SYSTEM AGENTS;

CHEMICAL STRUCTURE; CHINESE MEDICINE; DEMENTIA; DRUG ACTIVITY; NONHUMAN; REVIEW;

CENTRAL NERVOUS SYSTEM AGENTS; DEMENTIA; MEDICINE, CHINESE TRADITIONAL;

EID: 69849105403     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0900400629     Document Type: Review

References (55)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M, Alzheimer's Disease International. (2005) Global prevalence of dementia: a Delphi consensus study. The Lancet, 366, 2112-2117.
2. (a) Lin HQ, Ho MT, Lau LS, Wong KK, Shaw PC, Wan DC. (2008) Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease. Chemico-Biological Interactions, 175, 352-354;
3. (b) Peng Y, Li XB, Yang JY, Wu CF. (2005) Progress on the TCM research in prevention and treatment of Alzheimer's disease. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica, 7, 63-67;
4. (c) Wu L, Cheng SY, Wang Q, Chen YB. (2004) Advance on the pharmacological effects of active components of Chinese herbs for Alzheimer's disease. China Journal of Chinese Materia Medica, 29, 387-389.
5. Howes MJ, Perry NS, Houghton PJ. (2003) Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytotherapy Research, 17, 1-18.
6. Adams M, Gmünder F, Hamburger M. (2007) Plants traditionally used in age related brain disorders - a survey of ethnobotanical literature. Journal of Ethnopharmacology, 113, 363-381. (Pubitemid 47361572)
7. Zhou L, Zhang WH, Zeng LH, Jia B. (2005) Research on pharmaceutic rules of traditional Chinese medicine in treating senile dementia. Liaoning Journal of Traditional Chinese Medicine, 32, 243-244.
8. Howes MJ, Houghton PJ. (2003) Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacology, Biochemistry and Behavior, 75, 513-527.
9. (a) Mukherjee PK, Kumar V, Mal M, Houghton PJ. (2007) Acetylcholinesterase inhibitors from plants. Phytomedicine, 14, 289-300;
10. (b) Hu HF, Zhu BQ, Gong BY. (1999) Advance on acetylcholinesterase and its inhibitors. World Notes on Antibiotics, 20, 81-87;
11. (c) Yang JH, Tao YY, Zhang YM, Chen YG. (2006) Advance on acetylcholinesterase inhibitors from medicinal plants. Yunnan Chemical Technology, 33, 78-82;
12. (d) Hostettmann K, Borloz A, Urbain A, Marston A. (2007) Natural products inhibitors of acetylcholinesterase. Current Organic Chemistry, 10, 825-847.
13. Houghton PJ, Ren Y, Howes MJ. (2006) Acetylcholinesterase inhibitors from plants and fungi. Natural Product Reports, 23, 181-199.
14. (a) Wang R, Yan H, Tang XC. (2006) Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacologica Sinica, 27, 1-26;
15. (b) Zhang HY, Tang XC. (2006) Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease. Trends in Pharmacological Sciences, 27, 619-625.
16. Ji HF, Zhang HY. (2008) Multipotent natural agents to combat Alzheimer's disease. Functional spectrum and structural features. Acta Pharmacologica Sinica, 29, 143-151.
17. Kuriyama S, Hozawa A, Ohmori K, Shimazu T, Matsui T, Ebihara S, Awata S, Nagatomi R, Arai H, Tsuji I. (2006) Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project. American Journal of Clinical Nutrition, 83, 355-361.
18. He M, Yan XJ, Zhou JJ, Xie GR. (2001) Traditional Chinese medicine database (TCMD) and application on the Web. Journal of Chemical Information and Computer Sciences, 41, 273-277.
19. MDL Drug Data Report (MDDR). (2004) MDL Information Systems Inc., San Leandro, CA (USA) (http://www.mdl.com)
20. (a) Dufouil C, Richard F, Fiévet N, Dartigues JF, Ritchie K, Tzourio C, Amouyel P, Alpérovitch A. (2005) APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the three-city study. Neurology, 64, 1531-1538;
21. (b) Majeski EI, Widener CE, Basile J. (2004) Hypertension and dementia: does blood pressure control favorably affect cognition? Current Hypertension Reports, 6, 357-362;
22. (c) Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. (2002) Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia aging study. Annals of Neurology, 52, 168-174;
23. (d) Biessels GJ, Deary IJ, Ryan CM. (2008) Cognition and diabetes: a lifespan perspective. The Lancet Neurology, 7, 184-190;
24. (e) Cole AR, Astell A, Green C, Sutherland C. (2007) Molecular connexions between dementia and diabetes. Neuroscience & Biobehavioral Reviews, 31, 1046-1063.
25. (a) Vecka M, Tvrzická E, Stanková B, Novák F, Nováková O, Zák A. (2004) Hypolipidemic drugs can change the composition of rat brain lipids. The Tohoku Journal of Experimental Medicine, 204, 299-308;
26. (b) Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. (2000) Statins and the risk of dementia. The Lancet, 356, 1627-1631, Erratum in: 357, 562;
27. (c) Poon IO. (2008) Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. Pharmacotherapy, 28, 366-375;
28. (d) Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH. (2003) Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Annals of Epidemiology, 13, 369-376;
29. (d) Sugaya K, Uz T, Kumar V, Manev H. (2000) New anti-inflammatory treatment strategy in Alzheimer's disease. The Japanese Journal of Pharmacology, 82, 85-94;
30. (e) Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN. (2004) Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology, 23, 159-169.
31. Gardner M, Ditmanson L, Garrett RW, Luu T, Meiling F. (2000) Anticonvulsant use in treating dementia-related agitation. Journal of Pharmacy Practice, 13, 308-315.
32. (a) Tian R, Mu BL, Shi ZG. (2006) Research status of the effect of Acorus gramineus on central nervous system. Chinese Journal of Information on Traditional Chinese Medicine, 13, 101-103;
33. (b) Zhang ZJ. (2004) Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sciences, 75, 1659-1699.
34. Editorial Committee of Chinese Materia Medica. (1999) Chinese Materia Medica, 1st ed., Shanghai Science and Technology Publishers, Shanghai, China.
35. Chevallier A. (Translated by Liang LX, Jiang HB, Chen YP, Xu DY, Qin HZ, Chen JH, Liu XY, Huang M, Tan Q. (2003) Encyclopedia of Medicinal Plants, 1st ed. Guangxi Science and Technology Publishers, Nanning, China, 57.
36. Pandey MM, Govindarajan R, Khatoon S, Ajay KSR, Mehrotra S. (2007) Pharmacognostical studies of Polygonatum cirrifolium and Polygonatum verticillatum. Journal of Herbs, Spices and Medicinal Plants, 12, 37-48.
37. Li XJ, Zhang HY. (2008) Western healers in traditional Chinese medicine. EMBO Reports, 9, 112-113. (Pubitemid 351223443)
38. Kong DX, Li XJ, Zhang HY. (2008) Convergent evolution of medicines. ChemMedChem, 3, 1169-1171.
39. Mattson MP. (2004) Pathways towards and away from Alzheimer's disease. Nature, 430, 631-639.
40. Maggini M, Vanacore N, Raschetti R. (2006) Cholinesterase inhibitors: drugs looking for a disease? PLoS Medicine, 3, e140.
41. (a) Zhang HY. (2005) One-compound-multiple-targets strategy to combat Alzheimer's disease. FEBS Letters, 579, 5260-5264;
42. (b) Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C. (2008) Multi-target-directed ligands to combat neurodegenerative diseases. Journal of Medicinal Chemistry, 51, 347-372.
43. (a) Qiu J. (2007) Traditional medicine: a culture in the balance. Nature, 448, 126-128;
44. (b) Li XJ, Zhang HY. (2008) Synergy in natural medicines: implications for drug discovery. Trends in Pharmacological Sciences, 29, 331-332;
45. (c) Kong DX, Li XJ, Zhang HY. (2009) Where is the hope for drug discovery? Let history tell the future. Drug Discovery Today, 14, 115-119.
46. (a) Xu JY, Wang L, Wang Q, Lin XY, Dai ZY, Rong RH. (2003) Progress and development strategies on Chinese herbs prescriptions to treat the senile dementia. Medical Journal of the Chinese People's Armed Police Forces, 14, 241-243;
47. (b) Chen K, Chen KJ. (1995) Preliminary study of traditional Chinese medicine in the treatment of senile dementia. Chinese Journal of Integrated Traditional and Western Medicine, 15, 120-123;
48. (c) Tan RA, Cai JY, Huang ZY. (2004) Progress on the research of TCM in prevention and treatment of senile dementia. China Prescription Drug, 8, 63-66;
49. (d) Sun HY. (2004) Effect of Buzhi Yinao decoction on 40 cases of senile dementia. Jiangsu Journal of Traditional Chinese Medicine, 25, 29-30;
50. (e) Guo XX. (1999) Pharmacological research on Chinese herbs prescriptions in preventing and the treatment of the senile dementia. Chinese Traditional and Herbal Drugs, 1, 70-72;
51. (f) Zhu WM, Hu HY. (2005) Clinical research status of traditional Chinese medicine in the Alzheimer's disease. Journal of Traditional Chinese Medicine, 46, 389-391;
52. (g) Zhang SL. (2004) Effect of Jiannao Yizhi decoction on 36 cases of senile dementia. Chinese Journal of Integrated Traditional and Western Medicine, 24, 162;
53. (h) Gao Y, Li YT, Zheng XQ. (2006) Curative effect of Yinao Tongmai decoction on 50 cases of senile dementia. Chinese Journal of Gerontology, 26, 100-101;
54. (i) Wang DL. (2006) 64 Cases of senile dementia in Zengzhi decoction. Journal of Henan University of Chinese Medicine, 21, 45.
55. Stone R. (2008) Biochemistry: lifting the veil on traditional Chinese medicine. Science, 319, 709-710.